China looks to ban foreign acquisitions of critical biopharma platforms — Live Feedhttps://www.live-feeds.com/feed/china-looks-to-ban-foreign-acquisitions-of-critical-biopharma-platformsContinuously updated, source-cited coverage. China Targets Foreign Biopharma and Tech Acquisitionshttps://www.live-feeds.com/feed/china-looks-to-ban-foreign-acquisitions-of-critical-biopharma-platformshttps://www.live-feeds.com/feed/china-looks-to-ban-foreign-acquisitions-of-critical-biopharma-platforms#u143245Wed, 21 Oct 2026 12:55:31 +0000China is moving to block foreign acquisitions of critical biopharma platforms, alongside tightening controls on broader technology exports. Beijing cites national security risks amid mounting rivalry with the United States. The proposed measures span several sectors, targeting artificial intelligence exports, specific solar manufacturing technologies, and now biopharmaceutical assets. This broad regulatory push highlights an intensifying state effort to retain domestic control over strategic industries and advanced scientific capabilities.Why it mattersThe tightening restrictions reflect Beiji